The present invention provides novel salts of raltegravir, processes for their preparation and pharmaceutical compositions comprising them. The present invention also provides crystalline sodium salt of raltegravir, process for its preparation and pharmac
-
Paragraph 0192
(2013/06/05)
Crystalline sodium salt of an HIV integrase inhibitor
The present invention refers to a crystalline sodium salt of a compound of formula I (INN: Raltegravir) or a hydrate/solvate thereof as well as a process for obtaining the same.
-
Page/Page column 5-6
(2012/12/13)
RALTEGRAVIR SALTS AND CRYSTALLINE FORMS THEREOF
The present invention includes new salts of Raltegravir and crystalline forms thereof, pharmaceutical compositions containing the salts or crystalline forms, methods of using the salts or crystalline forms or the compositions to treat HIV infection or to prepare medicament for treating HIV infection, and a process for preparing Raltegravir potassium.
-
(2011/10/13)
SALTS OF RALTEGRAVIR
The present invention provides novel salts of raltegravir, processes for their preparation and pharmaceutical compositions comprising them. The present invention also provides crystalline sodium salt of raltegravir, process for its preparation and pharmac
-
Page/Page column 18
(2011/12/14)
More Articles about upstream products of 1292804-07-9
Get Best Price for1292804-07-9N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl] amino}ethyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide sodium salt